Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 4371-4380 Newer>

The Motley Fool November 10, 2004 Tom Taulli	Small-Cap IPOs Back in Action And they're just as volatile as ever.
The Motley Fool November 10, 2004 Dave Marino-Nachison	Investors Adjusting to Larger CVS The drugstore company's chains have done nothing but rise since the Eckerd buy. Investors have pulled the company's shares steadily upward since the merger closed.
The Motley Fool November 10, 2004 Seth Jayson	No Big Glitch at Abercrombie & Fitch Meager sales gains aren't much cause for worry at the clothing retailer. There's good cause to have faith in this stock.
The Motley Fool November 10, 2004 Rick Aristotle Munarriz	When NTN Mattered Shareholders can take some comfort in knowing that their stock has tripled over the past two years, but the gaming/software company could have been a household word.
The Motley Fool November 10, 2004 Rick Aristotle Munarriz	Netflix Sees Green Yes, the company will be barely profitable next year, but the aggressive pricing has the company confident that it may double its subscriber base by the end of next year.
The Motley Fool November 9, 2004 Lawrence Meyers	3M Looks Mmm-Mmm Good It's easy to overlook this stalwart, but doing so means missing out on a solid investment. Its stock price has doubled over the past five years and quadrupled over the past 15 years.
The Motley Fool November 9, 2004 Chris Mallon	One Hot Buying Opportunity Univision issues a warning, and the stock responds. Is it time to buy?
The Motley Fool November 9, 2004 Marko Djuranovic	DVD Rentals for $15.99? As part of a special promotion, Blockbuster has cut prices again. But will it be enough?
The Motley Fool November 9, 2004 W.D. Crotty	Midway to Profitability The video game developer is moving in the right direction, despite an "unprofitable" image it needs to shake. Its extremely high valuation relative to its peers should keep the cap on the stock price.
The Motley Fool November 9, 2004 Rich Smith	Veni Vidi Ventiv The pharma facilitator boosts revenues and profits. Were the company to rein in its dilution, it's not inconceivable that in the months to come, it might earn itself a recommendation as a Hidden Gem.
<Older 4371-4380 Newer> Return to current articles.